Clinical Trial Update: Gemcitabine in Treating Patients With Newly Diagnosed, Relapsed, or Chemotherapy-Resistant Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine for mantle cell lymphoma in patients who are newly diagnosed, relapsed, or chemotherapy-resistant; the study status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Lymphoma | Phase 2 | Status: COMPLETED